- Arendse, LB, Murithi, JM, Qahash, T, Pasaje, CFA, Godoy, LC, Dey, S et al.. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med. 2022;14 (667):eabo7219. doi: 10.1126/scitranslmed.abo7219. PubMed PMID:36260689 .
- Laleu, B, Rubiano, K, Yeo, T, Hallyburton, I, Anderson, M, Crespo-Fernandez, B et al.. Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem. 2022;17 (22):e202200393. doi: 10.1002/cmdc.202200393. PubMed PMID:36129427 PubMed Central PMC9827907.
- Tye, MA, Payne, NC, Johansson, C, Singh, K, Santos, SA, Fagbami, L et al.. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance. Nat Commun. 2022;13 (1):4976. doi: 10.1038/s41467-022-32630-4. PubMed PMID:36008486 PubMed Central PMC9403976.
- Xie, SC, Metcalfe, RD, Dunn, E, Morton, CJ, Huang, SC, Puhalovich, T et al.. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy. Science. 2022;376 (6597):1074-1079. doi: 10.1126/science.abn0611. PubMed PMID:35653481 PubMed Central PMC7613620.
- Ottilie, S, Luth, MR, Hellemann, E, Goldgof, GM, Vigil, E, Kumar, P et al.. Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance. Commun Biol. 2022;5 (1):128. doi: 10.1038/s42003-022-03076-7. PubMed PMID:35149760 PubMed Central PMC8837787.
Search PubMed